Literature DB >> 31273548

Sensitive detection of lung cancer biomarkers using an aptameric graphene-based nanosensor with enhanced stability.

Zhuang Hao1, Yunlu Pan2, Cong Huang1, Ziran Wang1, Xuezeng Zhao1.   

Abstract

We present an electrolyte-gated graphene field effect transistor (GFET) nanosensor using aptamer for rapid, highly sensitive and specific detection of a lung cancer biomarker interleukin-6 (IL-6) with enhanced stability. The negatively charged aptamer folds into a compact secondary conformation upon binding with IL-6, thus altering the carrier concentration of graphene and yielding a detectable change in the drain-source current Ids. Aptamer has smaller size than other receptors (e.g. antibodies), making it possible to bring the charged IL-6 more closely to the graphene surface upon affinity binding, thereby enhancing the sensitivity of the detection. Thanks to the higher stability of aptamer over antibodies, which degrade easily with increasing storage time, consistent sensing performance was obtained by our nanosensor over extended-time (>24 h) storage at 25 °C. Additionally, due to the GFET-enabled rapid transduction of the affinity recognition to IL-6, detection of IL-6 can be achieved in several minutes (<10 min). Experimental results indicate that this nanosensor can rapidly and specifically respond to the change in IL-6 levels with high consistency after extended-time storage and a detection limit (DL) down to 139 fM. Therefore, our nanosensor holds great potential for lung cancer diagnosis at its early stage.

Entities:  

Keywords:  Aptamer; Biosensing; Graphene; Interleukin-6 (IL-6); Lung cancer biomarker

Year:  2019        PMID: 31273548     DOI: 10.1007/s10544-019-0409-6

Source DB:  PubMed          Journal:  Biomed Microdevices        ISSN: 1387-2176            Impact factor:   2.838


  6 in total

Review 1.  Oncological Ligand-Target Binding Systems and Developmental Approaches for Cancer Theranostics.

Authors:  Jaison Jeevanandam; Godfred Sabbih; Kei X Tan; Michael K Danquah
Journal:  Mol Biotechnol       Date:  2021-01-09       Impact factor: 2.695

Review 2.  Aptamers for Proteins Associated with Rheumatic Diseases: Progress, Challenges, and Prospects of Diagnostic and Therapeutic Applications.

Authors:  Elizaveta A Shatunova; Maksim A Korolev; Vitaly O Omelchenko; Yuliya D Kurochkina; Anna S Davydova; Alya G Venyaminova; Mariya A Vorobyeva
Journal:  Biomedicines       Date:  2020-11-22

Review 3.  Graphene-Based Biosensors for Molecular Chronic Inflammatory Disease Biomarker Detection.

Authors:  Isidro Badillo-Ramírez; Yojana J P Carreón; Claudia Rodríguez-Almazán; Claudia M Medina-Durán; Selene R Islas; José M Saniger
Journal:  Biosensors (Basel)       Date:  2022-04-14

Review 4.  Aptamer-based biosensors for the diagnosis of sepsis.

Authors:  Lubin Liu; Zeyu Han; Fei An; Xuening Gong; Chenguang Zhao; Weiping Zheng; Li Mei; Qihui Zhou
Journal:  J Nanobiotechnology       Date:  2021-07-19       Impact factor: 10.435

Review 5.  Aptamers: a novel targeted theranostic platform for pancreatic ductal adenocarcinoma.

Authors:  Q Li; S H Maier; P Li; J Peterhansl; C Belka; J Mayerle; U M Mahajan
Journal:  Radiat Oncol       Date:  2020-08-05       Impact factor: 3.481

Review 6.  Electrochemical sensing of blood proteins for mild traumatic brain injury (mTBI) diagnostics and prognostics: towards a point-of-care application.

Authors:  Nadezda Pankratova; Milica Jović; Marc E Pfeifer
Journal:  RSC Adv       Date:  2021-05-12       Impact factor: 4.036

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.